Immunity to and frequency of reinfection with respiratory syncytial virus
- PMID: 2010624
- DOI: 10.1093/infdis/163.4.693
Immunity to and frequency of reinfection with respiratory syncytial virus
Abstract
To better understand the duration of immunity against respiratory syncytial virus (RSV) and the role of serum antibodies to the surface glycoproteins, F and G, in susceptibility to reinfection, 15 adults with previous natural RSV infection were challenged with RSV of the same strain group (A) at 2, 4, 8, 14, 20, and 26 months after natural infection. By 2 months about one-half and by 8 months two-thirds of the subjects became reinfected. Each challenge resulted in infection in at least one-fourth of the subjects. Within 26 months 73% had two or more and 47% had three or more infections. The duration of immunity tended to increase after two closely spaced infections. Higher neutralizing, F and GA antibody levels before challenge correlated significantly with protection against infection. However, even in subjects with the highest antibody levels, the risk of reinfection was 25%. Specific nasal IgA antibody titers did not correlate significantly with protection. This suggests that humoral neutralizing, F, and G antibodies correlate with resistance to reinfection, but protection is far from complete and is of short duration.
Similar articles
-
Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults.J Infect Dis. 2004 Jul 15;190(2):373-8. doi: 10.1086/421524. Epub 2004 Jun 18. J Infect Dis. 2004. PMID: 15216475
-
Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.J Clin Microbiol. 1986 Jun;23(6):1009-14. doi: 10.1128/jcm.23.6.1009-1014.1986. J Clin Microbiol. 1986. PMID: 3754878 Free PMC article.
-
The immunologic response to infection with respiratory syncytial virus in infants.J Infect Dis. 1978 Jul;138(1):24-32. doi: 10.1093/infdis/138.1.24. J Infect Dis. 1978. PMID: 355574
-
[Effect of the humoral immune response on the pathogenesis of respiratory syncytial virus (RSV) infection].Immun Infekt. 1993 Jun;21(3):75-7. Immun Infekt. 1993. PMID: 8335338 Review. German.
-
Immunity to human and bovine respiratory syncytial virus.Arch Virol. 1990;112(1-2):1-25. doi: 10.1007/BF01348982. Arch Virol. 1990. PMID: 2196033 Review.
Cited by
-
Analysis of Human RSV Immunity at the Molecular Level: Learning from the Past and Present.PLoS One. 2015 May 22;10(5):e0127108. doi: 10.1371/journal.pone.0127108. eCollection 2015. PLoS One. 2015. PMID: 26001197 Free PMC article. Review.
-
Environmental drivers of the spatiotemporal dynamics of respiratory syncytial virus in the United States.PLoS Pathog. 2015 Jan 8;11(1):e1004591. doi: 10.1371/journal.ppat.1004591. eCollection 2015 Jan. PLoS Pathog. 2015. PMID: 25569275 Free PMC article.
-
Viral and host factors in human respiratory syncytial virus pathogenesis.J Virol. 2008 Mar;82(5):2040-55. doi: 10.1128/JVI.01625-07. Epub 2007 Oct 10. J Virol. 2008. PMID: 17928346 Free PMC article. Review. No abstract available.
-
Differentiation and immune function of human dendritic cells following infection by respiratory syncytial virus.Clin Exp Immunol. 2006 Mar;143(3):513-22. doi: 10.1111/j.1365-2249.2005.03004.x. Clin Exp Immunol. 2006. PMID: 16487251 Free PMC article.
-
G protein variation in respiratory syncytial virus group A does not correlate with clinical severity.J Clin Microbiol. 2000 Oct;38(10):3849-52. doi: 10.1128/JCM.38.10.3849-3852.2000. J Clin Microbiol. 2000. PMID: 11015418 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous